Korse CM - Search Results

1

Elevated Pretreatment CEA and CA19-9 Levels are Related to Early Treatment Failure in Esophageal Adenocarcinoma.

van der Kaaij RT, Voncken FEM, van Dieren JM, Snaebjornsson P, Korse CM, Grootscholten C, Aleman BMP, van Sandick JW. van der Kaaij RT, et al. Among authors: korse cm. Am J Clin Oncol. 2019 Apr;42(4):345-350. doi: 10.1097/COC.0000000000000525. Am J Clin Oncol. 2019. PMID: 30724779

2

Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.

Korse CM, Taal BG, de Groot CA, Bakker RH, Bonfrer JM. Korse CM, et al. J Clin Oncol. 2009 Sep 10;27(26):4293-9. doi: 10.1200/JCO.2008.18.7047. Epub 2009 Aug 10. J Clin Oncol. 2009. PMID: 19667278

3

Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin.

Stiekema A, Boldingh QJ, Korse CM, van der Noort V, Boot H, van Driel WJ, Kenter GG, Lok CA. Stiekema A, et al. Among authors: korse cm. Gynecol Oncol. 2015 Mar;136(3):562-6. doi: 10.1016/j.ygyno.2014.12.037. Epub 2015 Jan 2. Gynecol Oncol. 2015. PMID: 25560808

4

Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancer.

Muller M, Hoogendoorn R, Moritz RJG, van der Noort V, Lanfermeijer M, Korse CM, van den Broek D, Ten Hoeve JJ, Baas P, van Rossum HH, van den Heuvel MM. Muller M, et al. Among authors: korse cm. Tumour Biol. 2021;43(1):115-127. doi: 10.3233/TUB-211504. Tumour Biol. 2021. PMID: 34219680 Free article. Clinical Trial.

5

Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer.

Bonfrer JM, Gaarenstroom KN, Kenter GG, Korse CM, Hart AA, Gallee MP, Helmerhorst TJ, Kenemans P. Bonfrer JM, et al. Among authors: korse cm. Gynecol Oncol. 1994 Dec;55(3 Pt 1):371-5. doi: 10.1006/gyno.1994.1309. Gynecol Oncol. 1994. PMID: 7530676

6

Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value.

Bonfrer JM, Korse CM, Verstraeten RA, van Kamp GJ, Hart GA, Kenemans P. Bonfrer JM, et al. Among authors: korse cm. Clin Chem. 1997 Mar;43(3):491-7. Clin Chem. 1997. PMID: 9068593

7

Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.

Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P. Bonfrer JM, et al. Among authors: korse cm. Anticancer Res. 1997 May-Jun;17(3C):2329-34. Anticancer Res. 1997. PMID: 9245246

8

Cyfra 21-1 and TPA as markers in malignant mesothelioma.

Bonfrer JM, Schouwink JH, Korse CM, Baas P. Bonfrer JM, et al. Among authors: korse cm. Anticancer Res. 1997 Jul-Aug;17(4B):2971-3. Anticancer Res. 1997. PMID: 9329578

9

TPA and CA 15.3 measurements for breast cancer monitoring in a routine setting.

Bonfrer JM, Korse CM. Bonfrer JM, et al. Among authors: korse cm. Int J Biol Markers. 1999 Jan-Mar;14(1):40-4. doi: 10.1177/172460089901400108. Int J Biol Markers. 1999. PMID: 10367249 Free article.

10

Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.

Smit LH, Korse CM, Hart AA, Bonfrer JM, Haanen JB, Kerst JM, Nieweg OE, de Gast GC. Smit LH, et al. Among authors: korse cm. Eur J Cancer. 2005 Feb;41(3):386-92. doi: 10.1016/j.ejca.2004.10.019. Eur J Cancer. 2005. PMID: 15691637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters